National Research Corporation (NRC)
| Previous close | 33.59 |
| Open | 33.36 |
| Bid | 33.60 x 100 |
| Ask | 33.79 x 100 |
| Day's range | 33.36 - 33.87 |
| 52-week range | 32.08 - 47.25 |
| Volume | |
| Avg. volume | 61,569 |
| Market cap | 806.499M |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | 27.03 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.48 (1.43%) |
| Ex-dividend date | 27 Mar 2024 |
| 1y target est | N/A |
- Business Wire
National Research Corporation to Broadcast Its First Quarter 2024 Conference Call Live on the Internet
LINCOLN, Neb., April 18, 2024--National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2024 first quarter earnings conference call on Wednesday, May 8, 2024. The Company’s results for the 2024 first quarter will be released after the close of the market on Tuesday, May 7, 2024.
- Business Wire
Veteran Patient Experience Executive Jennifer Baron Joins NRC Health as Its First Chief Experience Officer
LINCOLN, Neb., April 02, 2024--NRC Health, a recognized leader providing solutions and data driven insights for improving health care experiences, announced today the appointment of Jennifer Baron as the organization’s first chief experience officer. Baron’s addition is part of the organization’s continued investments in leadership and innovation to align with the evolving healthcare landscape.
- Business Wire
National Research Corporation Announces Fourth Quarter and Calendar Year 2023 Results
LINCOLN, Neb., February 13, 2024--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2023.
